Raymond James Trust N.A. Sells 2,324 Shares of MetLife, Inc. (NYSE:MET)

Raymond James Trust N.A. lessened its position in MetLife, Inc. (NYSE:METFree Report) by 8.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,768 shares of the financial services provider’s stock after selling 2,324 shares during the quarter. Raymond James Trust N.A.’s holdings in MetLife were worth $2,208,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its stake in shares of MetLife by 22.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after acquiring an additional 988,666 shares during the last quarter. Legal & General Group Plc boosted its stake in shares of MetLife by 5.4% during the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock valued at $371,993,000 after purchasing an additional 269,246 shares during the period. Envestnet Asset Management Inc. grew its holdings in shares of MetLife by 3.2% in the second quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider’s stock worth $226,358,000 after purchasing an additional 100,782 shares during the last quarter. AustralianSuper Pty Ltd increased its stake in shares of MetLife by 0.8% in the second quarter. AustralianSuper Pty Ltd now owns 2,063,607 shares of the financial services provider’s stock worth $144,845,000 after buying an additional 16,985 shares during the period. Finally, Swedbank AB raised its holdings in MetLife by 5.3% during the 3rd quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider’s stock valued at $162,499,000 after buying an additional 99,328 shares during the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Analysts Set New Price Targets

MET has been the topic of a number of recent analyst reports. Piper Sandler raised their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Wells Fargo & Company boosted their price target on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Jefferies Financial Group increased their price objective on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. Barclays reduced their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Thursday, October 31st. Finally, StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Fourteen analysts have rated the stock with a buy rating, According to MarketBeat, MetLife presently has an average rating of “Buy” and a consensus target price of $88.46.

Read Our Latest Report on MetLife

MetLife Stock Up 1.6 %

NYSE:MET opened at $86.59 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market cap of $59.96 billion, a P/E ratio of 17.46, a P/E/G ratio of 0.77 and a beta of 1.05. MetLife, Inc. has a fifty-two week low of $62.81 and a fifty-two week high of $86.94. The firm has a 50-day simple moving average of $82.48 and a two-hundred day simple moving average of $76.05.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.52%. MetLife’s dividend payout ratio (DPR) is presently 43.95%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.